Trials / Completed
CompletedNCT06724055
Diagnostic Prediction of Pancreatic Masses
Diagnostic Prediction of Pancreatic Masses: How to Avoid an Unnecessary Resection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn if a strategy can be developed for differentiating autoimmune pancreatitis (AIP) and primary pancreatic lymphoma (PPL) from pancreatic ductal adenocarcinoma (PDAC) in patients presenting with pancreatic masses. The main question it aims to answer is: What features, in the perspectives of clinical manifestation, laboratory tests, and imaging, can differentiate different kinds of pancreatic masses (AIP, PPL and PDAC)? Participants will not be given any interventions since this is a retrospective observational study.
Conditions
Timeline
- Start date
- 2002-01-01
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2024-12-09
- Last updated
- 2024-12-09
Source: ClinicalTrials.gov record NCT06724055. Inclusion in this directory is not an endorsement.